Home » Topics » BioWorld Science

BioWorld Science
RSS

Valneva initiates further phase III study of chikungunya vaccine candidate VLA-1553

Feb. 22, 2021

MMP-14 is a potential marker of vestibular schwannomas

Feb. 22, 2021

First-in-human data from SAD and MAD studies of LTI-291 in healthy volunteers

Feb. 22, 2021

Insmed reports phase I safety and PK data for treprostinil palmitil inhalation powder

Feb. 22, 2021

Positive topline data from pivotal phase III SKYLIGHT 1 and SKYLIGHT 2 studies of fezolinetant

Feb. 22, 2021

Zebrafish used to model perivascular glioblastoma multiforme invasion

Feb. 19, 2021

CHI3L1 is a risk marker for delirium in older patients undergoing surgery

Feb. 19, 2021

Dopamine progenitor cell product MSK-DA01 ameliorates Parkinsonian deficits in animal model

Feb. 19, 2021

Orinove initiates phase Ib trial of oral ORIN-1001 in IPF

Feb. 19, 2021

Rocket begins phase I study of RP-L401 in infantile malignant osteopetrosis

Feb. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...